Dr Vijay Patil is a Professor of Medical Oncology at the Tata Memorial Centre (TMC), Mumbai, India. His major field of work includes head and neck, neuro and thoracic oncology. His major areas of interest include neoadjuvant chemotherapy and triple metronomic chemotherapy in head and neck cancers. He is involved in various randomized trials as Principal Investigator and co-investigator. He has contributed to various studies majorly "low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial" and "Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/ early-failure oral cancer".